ArticleJournal of the American Heart Association2026
Implementing the GWTG-CAD Program in Mexico: Feasibility, Challenges and Lessons Learned for Acute and Secondary Prevention and Management.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe American Heart Association's GWTG (Get With The Guidelines) program has demonstrated effectiveness in standardizing and improving cardiovascular care in the United States. This study describes the implementation of the GWTG-CAD (GWTG-Coronary Artery Disease) program in Mexico and evaluates its impact on adherence to guideline-directed medical therapy and key clinical processes.
methodsPatients presenting with acute coronary syndrome from 10 hospitals in Mexico were included in the GWTG-CAD registry. Clinical processes and guideline-directed medical therapy use were assessed over the program's first 18 months, grouped into preprogram, 0 to 6 months, 6 to 12 months, and 12 to 18 months.
resultsA total of 2363 patients were analyzed. Mean age was 62.7±12.4 years, and 73.4% were male. ST-segment-elevation myocardial infarction was the initial presentation in 65.4% (n=1546). Substantial improvements were achieved in time-sensitive care. The proportion of patients receiving an ECG within 10 minutes of arrival increased from 61% preprogram to 93% at 12to 18 months (
conclusionsImplementation of the GWTG-CAD program in Mexico enabled the identification of critical barriers in cardiac care and supported targeted quality-improvement strategies, resulting in measurable improvements in clinical processes over 18 months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.